Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32885
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLu, Jean C-
dc.contributor.authorLee, Petrova-
dc.contributor.authorIerino, Francesco-
dc.contributor.authorMacIsaac, Richard J-
dc.contributor.authorEkinci, Elif I-
dc.contributor.authorO'Neal, David-
dc.date2023-
dc.date.accessioned2023-06-07T01:56:52Z-
dc.date.available2023-06-07T01:56:52Z-
dc.date.issued2023-05-10-
dc.identifier.citationJournal of Diabetes Science and Technology 2023en_US
dc.identifier.issn1932-2968-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32885-
dc.description.abstractDiabetes is the leading cause of chronic kidney disease (CKD) and end-stage kidney disease in the world. It is known that maintaining optimal glycemic control can slow the progression of CKD. However, the failing kidney impacts glucose and insulin metabolism and contributes to increased glucose variability. Conventional methods of insulin delivery are not well equipped to adapt to this increased glycemic lability. Automated insulin delivery (AID) has been established as an effective treatment in patients with type 1 diabetes mellitus, and there is emerging evidence for their use in type 2 diabetes mellitus. However, few studies have examined their role in diabetes with concurrent advanced CKD. We discuss the potential benefits and challenges of AID use in patients with diabetes and advanced CKD, including those on dialysis.en_US
dc.language.isoeng-
dc.subjectartificial pancreasen_US
dc.subjectautomated insulin deliveryen_US
dc.subjectchronic kidney diseaseen_US
dc.subjectdiabetesen_US
dc.subjectdialysisen_US
dc.subjectinsulin pumpen_US
dc.titleChallenges of Glycemic Control in People With Diabetes and Advanced Kidney Disease and the Potential of Automated Insulin Delivery.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Diabetes Science and Technologyen_US
dc.identifier.affiliationDepartment of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Fitzroy, VIC, Australiaen_US
dc.identifier.affiliationDepartment of Nephrology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australiaen_US
dc.identifier.affiliationSt Vincent's Institute of Medical Research, Fitzroy, VIC, Australiaen_US
dc.identifier.affiliationDepartment of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australiaen_US
dc.identifier.affiliationAustralian Centre for Accelerating Diabetes Innovations, The University of Melbourne, Parkville, VIC, Australiaen_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.doi10.1177/19322968231174040en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-3151-232Xen_US
dc.identifier.orcid0000-0002-0870-4032en_US
dc.identifier.pubmedid37162092-
dc.description.startpage19322968231174040-
local.name.researcherEkinci, Elif I
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

68
checked on Feb 12, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.